These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156 [Abstract] [Full Text] [Related]
46. Comparison of different modalities of continuous renal replacement therapy with regional sodium citrate anticoagulation in paediatric patients. He J, Xiao Z, Zhou X, Cao J, Kang X, Zhang X. Int J Artif Organs; 2022 Dec; 45(12):997-1005. PubMed ID: 35903018 [Abstract] [Full Text] [Related]
47. Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy. Liao YJ, Zhang L, Zeng XX, Fu P. Chin Med J (Engl); 2013 Apr; 126(7):1344-9. PubMed ID: 23557569 [Abstract] [Full Text] [Related]
49. [Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI]. Schmitz M, Joannidis M, Czock D, John S, Jörres A, Klein SJ, Oppert M, Schwenger V, Kielstein J, Zarbock A, Kindgen-Milles D, Willam C. Med Klin Intensivmed Notfmed; 2018 Jun; 113(5):377-383. PubMed ID: 29737362 [Abstract] [Full Text] [Related]
54. Profound hypocalcaemia in a patient being anticoagulated with citrate for continuous renal replacement therapy. Morgan DJ, Ho KM. Anaesthesia; 2009 Dec; 64(12):1363-6. PubMed ID: 19849680 [Abstract] [Full Text] [Related]
55. Citrate anticoagulation for continuous renal replacement therapy in small children. Soltysiak J, Warzywoda A, Kociński B, Ostalska-Nowicka D, Benedyk A, Silska-Dittmar M, Zachwieja J. Pediatr Nephrol; 2014 Mar; 29(3):469-75. PubMed ID: 24337319 [Abstract] [Full Text] [Related]
56. Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19. Khadzhynov D, von dem Berge U, Muench F, Karaivanov S, Koerner R, Kruse JM, Zickler D, Budde K, Eckardt KU, Lehner LJ. J Crit Care; 2022 Feb; 67():126-131. PubMed ID: 34768173 [Abstract] [Full Text] [Related]
57. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial. Brain MJ, Roodenburg OS, Adams N, McCracken P, Hockings L, Musgrave S, Butt W, Scheinkestel C. Crit Care Resusc; 2014 Jun; 16(2):131-7. PubMed ID: 24888284 [Abstract] [Full Text] [Related]
58. Anticoagulation for renal replacement therapy: different methods to improve safety. Oudemans-van Straaten HM, Fiaccadori E, Baldwin I. Contrib Nephrol; 2010 Jun; 165():251-262. PubMed ID: 20427976 [Abstract] [Full Text] [Related]
59. [Choice and management of anticoagulation during CRRT]. Ricci D, Panicali L, Cavallari G, Facchini MG, Mancini E. G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983172 [Abstract] [Full Text] [Related]
60. Anticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit. Sponholz C, Bayer O, Kabisch B, Wurm K, Ebert K, Bauer M, Kortgen A. ScientificWorldJournal; 2014 Apr; 2014():808320. PubMed ID: 25548793 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]